enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Talimogene laherparepvec - Wikipedia

    en.wikipedia.org/wiki/Talimogene_laherparepvec

    It gained regulatory approval in 2005 from China's State Food and Drug Administration (SFDA) for the treatment of head and neck cancer. [17] Talimogene laherparepvec is the world's first approved oncolytic immunotherapy, i.e. it was also designed to provide systemic anti-tumor effects through the induction of an anti-tumor immune response.

  3. William Coley - Wikipedia

    en.wikipedia.org/wiki/William_Coley

    William Bradley Coley (January 12, 1862 – April 16, 1936) was an American bone surgeon and cancer researcher best known for his early contributions to the study of cancer immunotherapy, specifically causing infection as a way to fight cancer, a practice used as far back as 1550 BC. [1]

  4. Cancer immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Cancer_immunotherapy

    Cancer immunotherapy (immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight the disease. [1] It is an application of the fundamental research of cancer immunology ( immuno-oncology ) and a growing subspecialty of oncology .

  5. Immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Immunotherapy

    Immunotherapy or biological therapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies .

  6. Dendreon - Wikipedia

    en.wikipedia.org/wiki/Dendreon

    Dendreon Pharmaceuticals LLC is a biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.It consists of a mixture of the patient's own blood cells (autologous, with dendritic cells thought to be the most important) that have been incubated with the Dendreon PAP-GM-CSF fusion protein.

  7. PD-1 and PD-L1 inhibitors - Wikipedia

    en.wikipedia.org/wiki/PD-1_and_PD-L1_inhibitors

    In the cancer disease state, the interaction of PD-L1 on the tumor cells with PD-1 on a T-cell reduces T-cell function signals to prevent the immune system from attacking the tumor cells. [9] Use of an inhibitor that blocks the interaction of PD-L1 with the PD-1 receptor can prevent the cancer from evading the immune system in this way. [ 9 ]

  8. Which landmarks are affected by the wildfires in Los Angeles ...

    www.aol.com/landmarks-affected-wildfires-los...

    "State Parks was able to evacuate the horses and some of the cultural and historical artifacts, including artwork, at Will Rogers SHP ahead of the fire," the release noted. Both parks had been ...

  9. Ibritumomab tiuxetan - Wikipedia

    en.wikipedia.org/wiki/Ibritumomab_tiuxetan

    When approved, it was the most expensive medication available given in a single dose, costing over US$37,000 (€30,000) for the average dose. [ 10 ] [ 11 ] Compared with other monoclonal antibody treatments (many of which are well over $40,000 for a course of therapy), it may be considered cost effective.